TY - JOUR
T1 - Maternal Phthalates Exposure and Blood Pressure during and after Pregnancy in the PROGRESS Study
AU - Wu, Haotian
AU - Kupsco, Allison
AU - Just, Allan
AU - Calafat, Antonia M.
AU - Oken, Emily
AU - Braun, Joseph M.
AU - Sanders, Alison P.
AU - Mercado-Garcia, Adriana
AU - Cantoral, Alejandra
AU - Pantic, Ivan
AU - Téllez-Rojo, Martha M.
AU - Wright, Robert O.
AU - Baccarelli, Andrea A.
AU - Deierlein, Andrea L.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health/National Institute of Environmental Health Sciences (R00 ES023474 to A.L.D.; R00 ES027508 to A.P.S.; R01 ES021357 and P30 ES009089 to A.A.B.; R01 ES024381 to J.M.B.; and P30 ES023515, R01 ES013744, R01ES014930, and R24 ES028522 to R.O.W.). The funding source did not have any role in the interpretation of the study results, writing of the manuscript, or decision to submit for publication.
Publisher Copyright:
© 2021, Public Health Services, US Dept of Health and Human Services. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - BACKGROUND: Phthalate exposure is ubiquitous and may affect biological pathways related to regulators of blood pressure. Given the profound changes in vasculature during pregnancy, pregnant women may be particularly susceptible to the potential effects of phthalates on blood pressure. OBJECTIVES: We examined associations of phthalate exposure during pregnancy with maternal blood pressure trajectories from mid-pregnancy through 72 months postpartum. METHODS: Women with singleton pregnancies delivering a live birth in Mexico City were enrolled during the second trimester (n = 892). Spot urine samples from the second and third trimesters were analyzed for 15 phthalate metabolites. Blood pressure and covariate data were collected over nine visits through 72 months postpartum. We used linear, logistic, and linear mixed models; latent class growth models (LCGMs); and Bayesian kernel machine regression to estimate the relationship of urinary phthalate biomarkers with maternal blood pressure. RESULTS: As a joint mixture, phthalate biomarker concentrations during pregnancy were associated with higher blood pressure rise during mid-to-late gestation. With respect to individual biomarkers, second trimester concentrations of monobenzyl phthalate (MBzP) and di(2-ethylhexyl) phthalate bio-markers (∑DEHP) were associated with higher third trimester blood pressure. Two trajectory classes were identified by LCGM, characterized by increasing blood pressure through 72 months postpartum (“increase–increase”) or decreased blood pressure through 18 months postpartum with a gradual increase thereafter (“decrease–increase”). Increasing exposure to phthalate mixtures during pregnancy was associated with higher odds of being in the increase–increase class. Similar associations were observed for mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and dibutyl phthalate (∑DBP) biomarkers. When specific time periods were examined, we observed specific temporal relationships were observed for ∑DEHP, MECPTP, MBzP, and ∑DBP. DISCUSSION: In our cohort of pregnant women from Mexico City, exposure to phthalates and phthalate biomarkers was associated with higher blood pressure during late pregnancy, as well as with long-term changes in blood pressure trajectories.
AB - BACKGROUND: Phthalate exposure is ubiquitous and may affect biological pathways related to regulators of blood pressure. Given the profound changes in vasculature during pregnancy, pregnant women may be particularly susceptible to the potential effects of phthalates on blood pressure. OBJECTIVES: We examined associations of phthalate exposure during pregnancy with maternal blood pressure trajectories from mid-pregnancy through 72 months postpartum. METHODS: Women with singleton pregnancies delivering a live birth in Mexico City were enrolled during the second trimester (n = 892). Spot urine samples from the second and third trimesters were analyzed for 15 phthalate metabolites. Blood pressure and covariate data were collected over nine visits through 72 months postpartum. We used linear, logistic, and linear mixed models; latent class growth models (LCGMs); and Bayesian kernel machine regression to estimate the relationship of urinary phthalate biomarkers with maternal blood pressure. RESULTS: As a joint mixture, phthalate biomarker concentrations during pregnancy were associated with higher blood pressure rise during mid-to-late gestation. With respect to individual biomarkers, second trimester concentrations of monobenzyl phthalate (MBzP) and di(2-ethylhexyl) phthalate bio-markers (∑DEHP) were associated with higher third trimester blood pressure. Two trajectory classes were identified by LCGM, characterized by increasing blood pressure through 72 months postpartum (“increase–increase”) or decreased blood pressure through 18 months postpartum with a gradual increase thereafter (“decrease–increase”). Increasing exposure to phthalate mixtures during pregnancy was associated with higher odds of being in the increase–increase class. Similar associations were observed for mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) and dibutyl phthalate (∑DBP) biomarkers. When specific time periods were examined, we observed specific temporal relationships were observed for ∑DEHP, MECPTP, MBzP, and ∑DBP. DISCUSSION: In our cohort of pregnant women from Mexico City, exposure to phthalates and phthalate biomarkers was associated with higher blood pressure during late pregnancy, as well as with long-term changes in blood pressure trajectories.
KW - Bayes Theorem
KW - Blood Pressure
KW - Environmental Exposure
KW - Environmental Pollutants/toxicity
KW - Female
KW - Humans
KW - Maternal Exposure
KW - Phthalic Acids/urine
KW - Pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85122903944&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122903944&partnerID=8YFLogxK
U2 - 10.1289/EHP8562
DO - 10.1289/EHP8562
M3 - Article
C2 - 34935432
AN - SCOPUS:85122903944
SN - 0091-6765
VL - 129
JO - Environmental health perspectives
JF - Environmental health perspectives
IS - 12
M1 - 127007
ER -